A phase III trial to evaluate the safety and efficacy of specific immunotherapy, recombinant idiotype conjugated to KLH with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma

Trial Profile

A phase III trial to evaluate the safety and efficacy of specific immunotherapy, recombinant idiotype conjugated to KLH with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jul 2007

At a glance

  • Drugs B cell lymphoma vaccine; Cyclophosphamide; Keyhole limpet haemocyanin; Prednisone; Vincristine
  • Indications Follicular lymphoma
  • Focus Registrational; Therapeutic Use
  • Sponsors Genitope Corporation
  • Most Recent Events

    • 09 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top